This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stock Under $10 that he thinks could potentially double or triple in the next 6 to 12-months. See what he's trading today with a 14-day FREE pass.

Insider Trading Alert - CFN, MPWR, LYV, ABC And GDOT Traded By Insiders

AmerisourceBergen (ABC) - FREE Research Report

McGee Henry Wadsworth III who is Director at AmerisourceBergen sold 9,449 shares at $69.62 on Jan. 7, 2014. Following this transaction, the Director owned 10,034 shares meaning that the stake was reduced by 48.5% with the 9,449-share transaction.

The shares most recently traded at $70.78, up $1.16, or 1.64% since the insider transaction. Historical insider transactions for AmerisourceBergen go as follows:

  • 4-Week # shares sold: 824
  • 12-Week # shares sold: 15,824
  • 24-Week # shares sold: 16,696

The average volume for AmerisourceBergen has been 1.5 million shares per day over the past 30 days. AmerisourceBergen has a market cap of $16.1 billion and is part of the services sector and wholesale industry. Shares are up 0.2% year-to-date as of the close of trading on Tuesday.

AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally. The stock currently has a dividend yield of 1.35%. The company has a P/E ratio of 33.2. Currently there are 6 analysts that rate AmerisourceBergen a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ABC - FREE

TheStreet Quant Ratings rates AmerisourceBergen as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full AmerisourceBergen Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

4 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
Submit an article to us!
DOW 16,562.92 +163.25 1.00%
S&P 500 1,929.85 +25.84 1.36%
NASDAQ 4,389.81 +73.7360 1.71%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs